147 related articles for article (PubMed ID: 8618938)
1. Endogenous basal nitric oxide production does not control myocardial oxygen consumption or function.
Sadoff JD; Scholz PM; Weiss HR
Proc Soc Exp Biol Med; 1996 Apr; 211(4):332-8. PubMed ID: 8618938
[TBL] [Abstract][Full Text] [Related]
2. Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo.
Sherman AJ; Davis CA; Klocke FJ; Harris KR; Srinivasan G; Yaacoub AS; Quinn DA; Ahlin KA; Jang JJ
Circulation; 1997 Mar; 95(5):1328-34. PubMed ID: 9054867
[TBL] [Abstract][Full Text] [Related]
3. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
4. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
[TBL] [Abstract][Full Text] [Related]
5. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.
Richard V; Berdeaux A; la Rochelle CD; Giudicelli JF
Br J Pharmacol; 1991 Sep; 104(1):59-64. PubMed ID: 1786519
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide does not modulate myocardial contractility acutely in in situ canine hearts.
Crystal GJ; Gurevicius J
Am J Physiol; 1996 May; 270(5 Pt 2):H1568-76. PubMed ID: 8928861
[TBL] [Abstract][Full Text] [Related]
7. A study on the effects of endogenous nitric oxide on coronary blood flow, myocardial oxygen extraction and cardiac contractility.
Okubo T; Suto N; Kudo S; Hanada H; Mikuniya A; Okumura K
Fundam Clin Pharmacol; 1999; 13(1):34-42. PubMed ID: 10027086
[TBL] [Abstract][Full Text] [Related]
8. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy.
Guo X; Kedem J; Weiss HR; Tse J; Roitstein A; Scholz PM
J Cardiovasc Pharmacol; 1996 Mar; 27(3):392-400. PubMed ID: 8907801
[TBL] [Abstract][Full Text] [Related]
11. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide does not modulate the increases in blood flow, O2 consumption, or contractility during CaCl2 administration in canine hearts.
Crystal GJ; Zhou X
Cardiovasc Res; 1999 Apr; 42(1):232-9. PubMed ID: 10435015
[TBL] [Abstract][Full Text] [Related]
13. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs.
Tayama S; Okumura K; Matsunaga T; Tsunoda R; Tabuchi T; Iwasa A; Yasue H
Jpn Circ J; 1998 May; 62(5):371-8. PubMed ID: 9626906
[TBL] [Abstract][Full Text] [Related]
14. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
Szigeti Z; Simon K; Parratt JR; Végh A
Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
[TBL] [Abstract][Full Text] [Related]
15. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy.
Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM
J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596
[TBL] [Abstract][Full Text] [Related]
16. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of nitric oxide synthase in human skin.
Goldsmith PC; Leslie TA; Hayes NA; Levell NJ; Dowd PM; Foreman JC
J Invest Dermatol; 1996 Jan; 106(1):113-8. PubMed ID: 8592060
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-derived nitric oxide does not modulate metabolic coronary vasodilation induced by tachycardia in dogs.
Katsuda Y; Egashira K; Akatsuka Y; Narishige T; Shimokawa H; Takeshita A
J Cardiovasc Pharmacol; 1995 Sep; 26(3):437-44. PubMed ID: 8583786
[TBL] [Abstract][Full Text] [Related]
20. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA
J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
